Literature DB >> 25172523

Insights into the antiatherogenic molecular mechanisms of andrographolide against Porphyromonas gingivalis-induced atherosclerosis in rabbits.

Rami Al Batran1, Fouad Al-Bayaty, Mazen M Jamil Al-Obaidi, Amer Ashrafi.   

Abstract

Atherosclerosis is the commonest and most important vascular disease. Andrographolide (AND) is the main bioactive component of the medicinal plant Andrographis paniculata and is used in traditional medicine. This study was aimed to evaluate the antiatherogenic effect of AND against atherosclerosis induced by Porphyromonas gingivalis in White New Zealand rabbits. Thirty rabbits were divided into five groups as follows: G1, normal group; G2-5, were orally challenged with P. gingivalis five times a week over 12 weeks; G2, atherogenic control group; G3, standard group treated with atorvastatin (AV) 5 mg/kg; and G4 and G5, treatment groups treated with AND 10 and 20 mg/kg, respectively over 12 weeks. Serums were subjected to antioxidant enzymatic and anti-inflammatory activities, and the aorta was subjected to histological analyses. Groups treated with AND showed a significant reversal of liver and renal biochemical changes, compared with the atherogenic control group. In the same groups, superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), total glutathione (GSH) levels in serum were significantly increased (P < 0.05), and lipid peroxidation (malondialdehyde (MDA)) levels were significantly decreased (P < 0.05), respectively. Furthermore, treated groups with AV and AND showed significant decrease in the level of VCAM-1 and ICAM-1 compared with the atherogenic control group. In aortic homogenate, the level of nitrotyrosine was significantly increased, while the level of MCP1 was significantly decreased in AV and AND groups compared with the atherogenic control group. In addition, staining the aorta with Sudan IV showed a reduction in intimal thickening plaque in AV and AND groups compared with the atherogenic control group. AND has showed an antiatherogenic property as well as the capability to reduce lipid, liver, and kidney biomarkers in atherogenic serum that prevents atherosclerosis complications caused by P. gingivalis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25172523     DOI: 10.1007/s00210-014-1041-x

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  44 in total

Review 1.  Complementary and alternative medicine.

Authors:  K H Neldner
Journal:  Dermatol Clin       Date:  2000-01       Impact factor: 3.478

Review 2.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

Authors:  Giovanni Targher; Christopher P Day; Enzo Bonora
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

Review 3.  The immune response in atherosclerosis: a double-edged sword.

Authors:  Göran K Hansson; Peter Libby
Journal:  Nat Rev Immunol       Date:  2006-06-16       Impact factor: 53.106

4.  Hypotensive activity of aqueous extract of Andrographis paniculata in rats.

Authors:  C Y Zhang; B K Tan
Journal:  Clin Exp Pharmacol Physiol       Date:  1996-08       Impact factor: 2.557

Review 5.  Nitric oxide and atherosclerosis.

Authors:  C Napoli; L J Ignarro
Journal:  Nitric Oxide       Date:  2001-04       Impact factor: 4.427

Review 6.  The role of peroxidases in the pathogenesis of atherosclerosis.

Authors:  Jong-Gil Park; Goo Taeg Oh
Journal:  BMB Rep       Date:  2011-08       Impact factor: 4.778

Review 7.  Animal models for the atherosclerosis research: a review.

Authors:  Li Xiangdong; Liu Yuanwu; Zhang Hua; Ren Liming; Li Qiuyan; Li Ning
Journal:  Protein Cell       Date:  2011-04-06       Impact factor: 14.870

Review 8.  Role of oxidative stress in atherosclerosis.

Authors:  David Harrison; Kathy K Griendling; Ulf Landmesser; Burkhard Hornig; Helmut Drexler
Journal:  Am J Cardiol       Date:  2003-02-06       Impact factor: 2.778

9.  Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis.

Authors:  K D O'Brien; M D Allen; T O McDonald; A Chait; J M Harlan; D Fishbein; J McCarty; M Ferguson; K Hudkins; C D Benjamin
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

10.  Antioxidant activities and lipid lowering effects of isoflavone in male rabbits.

Authors:  Mokhtar I Yousef; Kamel I Kamel; Alshaimaa M Esmail; Hoda H Baghdadi
Journal:  Food Chem Toxicol       Date:  2004-09       Impact factor: 6.023

View more
  4 in total

Review 1.  Andrographolide, a New Hope in the Prevention and Treatment of Metabolic Syndrome.

Authors:  Muhammad T Islam
Journal:  Front Pharmacol       Date:  2017-08-23       Impact factor: 5.810

Review 2.  Traditional Chinese Medicine Protects against Cytokine Production as the Potential Immunosuppressive Agents in Atherosclerosis.

Authors:  Yan Ren; Wei Qiao; Dongliang Fu; Zhiwei Han; Wei Liu; Weijie Ye; Zunjing Liu
Journal:  J Immunol Res       Date:  2017-09-06       Impact factor: 4.818

3.  Porphyromonas gingivalis-Induced MIF Regulates Intercellular Adhesion Molecule-1 Expression in EA.hy926 Cells and Monocyte-Endothelial Cell Adhesion Through the Receptors CD74 and CXCR4.

Authors:  Yun Wu; Wanyue Xu; Jingya Hou; Yanqing Liu; Rong Li; Jingbo Liu; Chen Li; Xiaolin Tang; Li Lin; Yaping Pan; Dongmei Zhang
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

Review 4.  Andrographolide, a Natural Antioxidant: An Update.

Authors:  Eugenie Mussard; Annabelle Cesaro; Eric Lespessailles; Brigitte Legrain; Sabine Berteina-Raboin; Hechmi Toumi
Journal:  Antioxidants (Basel)       Date:  2019-11-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.